Logo

American Heart Association

  32
  0


Final ID: Thu014

Checkpoint kinase-2 regulates cardiomyocyte cell cycle and ameliorates cardiac function after myocardial infarction

Abstract Body: Background: The adult mammalian heart exhibits limited regenerative capability, primarily due to the postnatal arrest of the cardiomyocyte (CM) cell cycle.
Aim: To elucidate the role of checkpoint kinase 2 (CHK2), a master regulator of cell cycle in DNA damage response pathway, in post-infarct heart failure.
Methods: We injected AAV9-TnT-CHK2shRNA 1-day post-myocardial infarction (MI, by mid-LAD ligation) to elucidate the effect of cardiomyocyte CHK2 suppression on cardiac function, scar size, and CM proliferation in mTmG lineage tracing mice one week after MI. We use Visium spatial transcriptomics to analyze differentially expressed genes across different regions and identify crucial gene programs modulated in different regions and clusters of cardiomyocytes after injury.
Results: The CHK2 and its active form, p-CHK2, significantly increased during development and post-MI. Spatial transcriptomic analysis indicated that two clusters of normal cardiomyocytes (most abundant in sham) were significantly lost in MI, and the CHK2shRNA-treated post-MI hearts maintained healthy CM clusters. Within the same clusters of “normal cardiomyocytes”, differentially expressed gene analysis shows upregulation of transcripts involved in the mitochondrial function, Ca-handling (SERCA2, RyR2), and better preservation of myofilaments (Myl9, Myh7, transgelin, etc) in the treated group. Changes in the expression of upstream transcriptional regulators suggest a shift from repressed metabolic states to an active state favorable for repair and adaptation. In parallel with the amelioration of transcriptional remodeling of the remaining viable cardiomyocytes, we observed increased GFP+ cardiomyocytes with multiple co-localized markers of cell cycles (BrdU, Ki-67, phospho-histone-3), attenuation of cardiac fibrosis, improvement of LV ejection fraction and prevention of adverse remodeling (LV chamber dilation) 1 week after MI.
Conclusions: Myocardial CHK2 suppression enhanced post-MI cardiac function and adverse remodeling, by promoting endogenous CM proliferation and creating a healthy microenvironment.
  • Dai, Dao-fu  ( Johns Hopkins Medicine , Baltimore , Maryland , United States )
  • Grueter, Chad  ( UNIVERSITY OF IOWA , Iowa City , Iowa , United States )
  • Daneshgar, Nastaran  ( University of Iowa , Iowa City , Iowa , United States )
  • Author Disclosures:
    Dao-Fu Dai: DO NOT have relevant financial relationships | Chad Grueter: DO NOT have relevant financial relationships | Nastaran Daneshgar: No Answer
Meeting Info:

Basic Cardiovascular Sciences 2025

2025

Baltimore, Maryland

Session Info:

Poster Session and Reception 2

Thursday, 07/24/2025 , 04:30PM - 07:00PM

Poster Session and Reception

More abstracts on this topic:
A Bridge from Sweet to Sour: A Case of Recurrent Myocardial Stunning in Diabetic Ketoacidosis

Satish Vikyath, Pargaonkar Sumant, Slipczuk Leandro, Schenone Aldo, Maliha Maisha, Chi Kuan Yu, Sunil Kumar Sriram, Borkowski Pawel, Vyas Rhea, Rodriguez Szaszdi David Jose Javier, Kharawala Amrin, Seo Jiyoung

A Novel Cardioprotective Mechanism in Myocardial Reperfusion Injury: Dual Neutrophil Modulation and ROS/HOCl Scavenging by an Atypical Chemokine

Zwissler Leon, Bernhagen Juergen, Cabrera-fuentes Hector Alejandro, Hernandez Resendiz Sauri, Yap En Ping, Schindler Lisa, Zhang Zhishen, Dickerhof Nina, Hampton Mark, Liehn Elisa, Hausenloy Derek

You have to be authorized to contact abstract author. Please, Login
Not Available